Lv1
100 积分 2024-03-14 加入
Current and future therapies for haemophilia—Beyond factor replacement therapies
2天前
已完结
Haemophilia
2天前
已完结
Hemophilia treatment innovation: 50 years of progress and more to come
3天前
已完结
Concizumab prophylaxis in people with haemophilia A or haemophilia B without inhibitors (explorer8): a prospective, multicentre, open-label, randomised, phase 3a trial
10天前
已关闭
Carfilzomib, dexamethasone, and daratumumab versus carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma (CANDOR): updated outcomes from a randomised, multicentre, open-label, phase 3 study
11天前
已完结
FRONTIER1: a partially randomized phase 2 study assessing the safety, pharmacokinetics, and pharmacodynamics of Mim8, a factor VIIIa mimetic
12天前
已完结
Lateral episiotomy or no episiotomy in vacuum assisted delivery in nulliparous women (EVA): multicentre, open label, randomised controlled trial
15天前
已完结
A Phase II Study of Acalabrutinib, Venetoclax, and Obinutuzumab (AVO) in a Treatment-Naive CLL Population Enriched for High-Risk Disease
18天前
已完结
Angiogenesis inhibition in metastatic colorectal cancer continuum of care
1个月前
已完结
The tyranny of non-inferiority trials
1个月前
已完结
皖公网安备34019202002308
